Eledon Pharmaceuticals (ELDN) Balance Sheet: Assets & Liabilities

Eledon Pharmaceuticals (ELDN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Eledon Pharmaceuticals reported total assets of $169.01M and total liabilities of $87.92M. Shareholders' equity was $81.08M, down 31.4% from $118.14M a year earlier. Total debt stood at $641.00K against $133.34M in cash and short-term investments, a net cash position of $132.69M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Eledon Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Eledon Pharmaceuticals, Inc. (ELDN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	22.81	20.55	4.61	56.41	84.83	114.20	8.79	12.97	17.23
Short-Term Investments	110.53	119.63	46.49	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	133.34	140.18	51.10	56.41	84.83	114.20	8.79	12.97	17.23
Accounts Receivable	0.51	0.63	0.00	0.00	0.00	0.11	0.25	0.59	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.00	0.00
Other Current Assets	0.01	3.55	5.03	0.03	0.03	1.33	0.05	0.71	1.77
Total Current Assets	135.69	143.73	56.13	59.52	88.35	115.63	9.97	14.28	19.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.61	0.93	0.37	0.74	0.77	0.14	0.32	0.01	0.03
Goodwill	0.00	0.00	0.00	0.00	48.65	48.65	0.00	1.87	1.87
Intangible Assets	32.39	32.39	32.39	32.39	32.39	32.39	0.00	0.00	0.00
Other Non-Current Assets	0.32	0.36	0.19	0.15	0.40	0.38	0.64	0.87	0.00
Total Non-Current Assets	33.32	33.68	32.94	33.28	82.20	81.56	0.96	2.75	1.89
Total Assets	169.01	177.41	89.07	92.79	170.55	197.19	10.93	17.03	20.89
Current Liabilities
Accounts Payable	3.63	5.83	0.97	2.20	1.81	1.37	0.33	0.69	0.42
Short-Term Debt	0.36	0.31	0.38	0.36	0.37	0.14	0.18	0.00	0.00
Accrued Liabilities	10.18	5.43	2.55	2.00	0.70	0.97	-	-	-
Other Current Liabilities	14.36	5.43	2.55	3.91	2.22	0.97	0.81	1.85	1.02
Total Current Liabilities	18.34	11.58	3.90	6.48	4.40	2.48	1.32	2.53	1.44
Non-Current Liabilities
Long-Term Debt	0.28	0.64	0.00	0.38	0.40	0.00	0.14	0.00	0.00
Deferred Tax Liabilities	2.19	2.18	1.75	1.75	1.75	4.11	0.00	0.00	0.00
Other Non-Current Liabilities	67.11	47.05	77.96	1.75	1.75	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	69.58	47.69	77.96	2.14	2.15	4.11	0.14	1.85	1.02
Total Liabilities	87.92	59.27	81.86	8.61	6.55	6.59	1.47	2.53	1.44
Stockholders' Equity
Common Stock	0.08	0.06	0.02	0.01	0.01	0.02	0.01	0.01	0.01
Retained Earnings	-401.20	-355.59	-319.40	-202.87	-114.90	-80.39	-57.58	-41.57	-27.51
Accumulated Other Comprehensive Income	0.02	0.03	0.00	-	0.00	0.00	-	0.00	0.00
Additional Paid-in Capital	482.19	417.95	270.89	287.03	278.88	270.97	67.03	56.05	46.95
Shares Outstanding	75.43	59.79	24.21	13.78	14.31	-	-	-	-
Total Stockholders' Equity	81.09	118.14	7.21	84.18	164.00	190.60	9.47	14.49	19.45
Total Liabilities & Equity	169.01	177.41	89.07	92.79	170.55	197.19	10.93	17.03	20.89

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Eledon Pharmaceuticals Balance Sheet

How much debt does Eledon Pharmaceuticals have?

Eledon Pharmaceuticals had total debt of $641.00K as of Dec 31, 2025, against $133.34M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $954.00K a year earlier.

What are Eledon Pharmaceuticals's total assets?

Eledon Pharmaceuticals reported total assets of $169.01M as of Dec 31, 2025, down 4.7% from $177.41M a year earlier. Total liabilities were $87.92M.

What is Eledon Pharmaceuticals's shareholders' equity?

Eledon Pharmaceuticals's shareholders' equity was $81.08M as of Dec 31, 2025, or about $1.07 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition